$ in millions, except per share amounts | ||||||||||||||||||||
Q3 2023 | Q3 2022 | Variance | YTD 2023 | YTD 2022 | Variance | |||||||||||||||
Pretax Income from Continuing Operations | $ | 38.4 | $ | 34.7 | $ | 3.7 | $ | 77.8 | $ | 163.5 | $ | (85.7) | ||||||||
Pretax Income from Continuing Operations Attributable to the Company1 | 17.6 | 27.2 | (9.6) | 73.7 | 133.7 | (60.0) | ||||||||||||||
Adjusted Pretax Income (Loss) from Continuing Operations Attributable to the Company1 | 10.1 | 27.2 | (17.1) | 90.7 | 134.3 | (43.6) | ||||||||||||||
Trade1 | 5.4 | 40.7 | (35.3) | 36.3 | 68.7 | (32.4) | ||||||||||||||
Renewables1 | 26.3 | 8.4 | 17.9 | 65.0 | 59.8 | 5.2 | ||||||||||||||
Nutrient & Industrial | (8.5) | (11.6) | 3.1 | 23.7 | 37.4 | (13.7) | ||||||||||||||
Other1 | (13.1) | (10.2) | (2.9) | (34.3) | (31.6) | (2.7) | ||||||||||||||
Net Income from Continuing Operations Attributable to the Company | 9.7 | 17.4 | (7.7) | 50.0 | 104.0 | (54.0) | ||||||||||||||
Adjusted Net Income from Continuing Operations Attributable to the Company1 | 4.6 | 17.4 | (12.8) | 63.7 | 105.6 | (41.9) | ||||||||||||||
Diluted Earnings Per Share from Continuing Operations (EPS) | 0.28 | 0.50 | (0.22) | 1.46 | 3.02 | (1.56) | ||||||||||||||
Adjusted Diluted Earnings Per Share from Continuing Operations1 | 0.13 | 0.50 | (0.37) | 1.86 | 3.07 | (1.21) | ||||||||||||||
EBITDA from Continuing Operations1 | 77.8 | 83.0 | (5.2) | 210.4 | 307.5 | (97.1) | ||||||||||||||
Adjusted EBITDA from Continuing Operations1 | $ | 70.3 | $ | 83.0 | $ | (12.7) | $ | 270.0 | $ | 308.2 | $ | (38.2) | ||||||||
1 Non-GAAP financial measures; see appendix for explanations and reconciliations. |
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Sales and merchandising revenues | $ | 3,635,691 | $ | 4,219,325 | $ | 11,537,112 | $ | 12,647,896 | |||||||||||||||
Cost of sales and merchandising revenues | 3,477,990 | 4,055,560 | 11,009,463 | 12,133,755 | |||||||||||||||||||
Gross profit | 157,701 | 163,765 | 527,649 | 514,141 | |||||||||||||||||||
Operating, administrative and general expenses | 126,306 | 115,539 | 359,548 | 330,085 | |||||||||||||||||||
Asset impairment | — | — | 87,156 | — | |||||||||||||||||||
Interest expense, net | 8,188 | 14,982 | 38,766 | 42,762 | |||||||||||||||||||
Other income, net | 15,178 | 1,475 | 35,623 | 22,185 | |||||||||||||||||||
Income before income taxes from continuing operations | 38,385 | 34,719 | 77,802 | 163,479 | |||||||||||||||||||
Income tax provision from continuing operations | 7,862 | 9,839 | 23,710 | 29,695 | |||||||||||||||||||
Net income from continuing operations | 30,523 | 24,880 | 54,092 | 133,784 | |||||||||||||||||||
Income from discontinued operations, net of income taxes | — | 19,392 | — | 18,099 | |||||||||||||||||||
Net income | 30,523 | 44,272 | 54,092 | 151,883 | |||||||||||||||||||
Net income attributable to noncontrolling interests | 20,815 | 7,524 | 4,088 | 29,827 | |||||||||||||||||||
Net income attributable to The Andersons, Inc. | $ | 9,708 | $ | 36,748 | $ | 50,004 | $ | 122,056 | |||||||||||||||
Earnings per share attributable to The Andersons, Inc. common shareholders: | |||||||||||||||||||||||
Basic earnings: | |||||||||||||||||||||||
Continuing operations | $ | 0.29 | $ | 0.51 | $ | 1.48 | $ | 3.08 | |||||||||||||||
Discontinued operations | — | 0.57 | — | 0.54 | |||||||||||||||||||
$ | 0.29 | $ | 1.08 | $ | 1.48 | $ | 3.62 | ||||||||||||||||
Diluted earnings: | |||||||||||||||||||||||
Continuing operations | $ | 0.28 | $ | 0.50 | $ | 1.46 | $ | 3.02 | |||||||||||||||
Discontinued operations | — | 0.56 | — | 0.53 | |||||||||||||||||||
$ | 0.28 | $ | 1.06 | $ | 1.46 | $ | 3.55 |
(in thousands) | September 30, 2023 | December 31, 2022 | September 30, 2022 | ||||||||||||||
Assets | |||||||||||||||||
Current assets: | |||||||||||||||||
Cash and cash equivalents | $ | 418,055 | $ | 115,269 | $ | 140,771 | |||||||||||
Accounts receivable, net | 816,686 | 1,248,878 | 990,531 | ||||||||||||||
Inventories | 985,292 | 1,731,725 | 1,556,426 | ||||||||||||||
Commodity derivative assets – current | 239,595 | 295,588 | 502,097 | ||||||||||||||
Other current assets | 67,471 | 74,493 | 75,402 | ||||||||||||||
Total current assets | 2,527,099 | 3,465,953 | 3,265,227 | ||||||||||||||
Other assets: | |||||||||||||||||
Goodwill | 128,542 | 129,342 | 129,342 | ||||||||||||||
Other intangible assets, net | 90,768 | 100,907 | 99,317 | ||||||||||||||
Right of use assets, net | 56,919 | 61,890 | 59,146 | ||||||||||||||
Other assets, net | 104,586 | 87,175 | 99,650 | ||||||||||||||
Total other assets | 380,815 | 379,314 | 387,455 | ||||||||||||||
Property, plant and equipment, net | 680,188 | 762,729 | 765,939 | ||||||||||||||
Total assets | $ | 3,588,102 | $ | 4,607,996 | $ | 4,418,621 | |||||||||||
Liabilities and equity | |||||||||||||||||
Current liabilities: | |||||||||||||||||
Short-term debt | $ | 14,138 | $ | 272,575 | $ | 652,947 | |||||||||||
Trade and other payables | 822,153 | 1,423,633 | 930,027 | ||||||||||||||
Customer prepayments and deferred revenue | 211,867 | 370,524 | 258,828 | ||||||||||||||
Commodity derivative liabilities – current | 142,511 | 98,519 | 137,168 | ||||||||||||||
Current maturities of long-term debt | 27,535 | 110,155 | 112,029 | ||||||||||||||
Accrued expenses and other current liabilities | 189,430 | 245,916 | 229,508 | ||||||||||||||
Total current liabilities | 1,407,634 | 2,521,322 | 2,320,507 | ||||||||||||||
Long-term lease liabilities | 32,883 | 37,147 | 34,779 | ||||||||||||||
Long-term debt, less current maturities | 569,730 | 492,518 | 497,988 | ||||||||||||||
Deferred income taxes | 58,217 | 64,080 | 59,079 | ||||||||||||||
Other long-term liabilities | 70,552 | 63,160 | 79,727 | ||||||||||||||
Total liabilities | 2,139,016 | 3,178,227 | 2,992,080 | ||||||||||||||
Total equity | 1,449,086 | 1,429,769 | 1,426,541 | ||||||||||||||
Total liabilities and equity | $ | 3,588,102 | $ | 4,607,996 | $ | 4,418,621 |
Nine months ended September 30, | |||||||||||
(in thousands) | 2023 | 2022 | |||||||||
Operating Activities | |||||||||||
Net income from continuing operations | $ | 54,092 | $ | 133,784 | |||||||
Income from discontinued operations, net of income taxes | — | 18,099 | |||||||||
Net income | 54,092 | 151,883 | |||||||||
Adjustments to reconcile net income to cash provided by (used in) operating activities: | |||||||||||
Depreciation and amortization | 93,800 | 101,266 | |||||||||
Gain on sale of business from discontinued operations | — | (27,091) | |||||||||
Asset impairment | 87,156 | — | |||||||||
Other | 1,347 | (1,296) | |||||||||
Changes in operating assets and liabilities: | |||||||||||
Accounts receivable | 406,263 | (140,866) | |||||||||
Inventories | 748,118 | 236,854 | |||||||||
Commodity derivatives | 99,479 | (104,901) | |||||||||
Other current and non-current assets | 2,048 | 2,000 | |||||||||
Payables and other current and non-current liabilities | (796,216) | (371,219) | |||||||||
Net cash provided by (used in) operating activities | 696,087 | (153,370) | |||||||||
Investing Activities | |||||||||||
Acquisition of businesses, net of cash acquired | (24,385) | — | |||||||||
Purchases of property, plant and equipment and capitalized software | (108,718) | (72,247) | |||||||||
Proceeds from sale of assets | 3,082 | 4,810 | |||||||||
Proceeds from sale of business from continuing operations | 10,318 | 5,171 | |||||||||
Proceeds from sale of business from discontinued operations | — | 56,302 | |||||||||
Purchases of Rail assets | — | (27,464) | |||||||||
Proceeds from sale of Rail assets | 2,871 | 36,706 | |||||||||
Other | (431) | (359) | |||||||||
Net cash (used in) provided by investing activities | (117,263) | 2,919 | |||||||||
Financing Activities | |||||||||||
Net receipts (payments) under short-term lines of credit | (261,152) | 361,318 | |||||||||
Proceeds from issuance of short-term debt | — | 350,000 | |||||||||
Payments of short-term debt | — | (550,000) | |||||||||
Proceeds from issuance of long-term debt | 100,000 | — | |||||||||
Payments of long-term debt | (42,734) | (22,585) | |||||||||
Contributions from noncontrolling interest owner | — | 2,450 | |||||||||
Distributions to noncontrolling interest owner | (44,304) | (34,930) | |||||||||
Payments of debt issuance costs | (769) | (7,802) | |||||||||
Dividends paid | (18,771) | (18,262) | |||||||||
Proceeds from exercises of stock options | — | 5,024 | |||||||||
Common stock repurchased | (1,747) | (6,769) | |||||||||
Value of shares withheld for taxes | (6,627) | (3,349) | |||||||||
Other | 258 | 394 | |||||||||
Net cash (used in) provided by financing activities | (275,846) | 75,489 | |||||||||
Effect of exchange rates on cash and cash equivalents | (192) | (711) | |||||||||
Increase (decrease) in cash and cash equivalents | 302,786 | (75,673) | |||||||||
Cash and cash equivalents at beginning of period | 115,269 | 216,444 | |||||||||
Cash and cash equivalents at end of period | $ | 418,055 | $ | 140,771 |
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands, except per share data) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Net income from continuing operations | $ | 30,523 | $ | 24,880 | $ | 54,092 | $ | 133,784 | |||||||||||||||
Net income attributable to noncontrolling interests | 20,815 | 7,524 | 4,088 | 29,827 | |||||||||||||||||||
Net income from continuing operations attributable to The Andersons, Inc. | 9,708 | 17,356 | 50,004 | 103,957 | |||||||||||||||||||
Adjustments: | |||||||||||||||||||||||
Gain on sale of assets | (5,643) | — | (5,643) | (3,762) | |||||||||||||||||||
Gain on cost method investment | (4,798) | — | (4,798) | — | |||||||||||||||||||
Transaction related compensation | 1,999 | — | 4,606 | — | |||||||||||||||||||
Gain on deconsolidation of joint venture | — | — | (6,544) | — | |||||||||||||||||||
Insured inventory recoveries | — | — | (16,080) | — | |||||||||||||||||||
Asset impairment including equity method investments | 963 | — | 45,413 | 4,455 | |||||||||||||||||||
Income tax impact of adjustments1 | 2,367 | — | (3,255) | 940 | |||||||||||||||||||
Total adjusting items, net of tax | (5,112) | — | 13,699 | 1,633 | |||||||||||||||||||
Adjusted net income from continuing operations attributable to The Andersons, Inc. | $ | 4,596 | $ | 17,356 | $ | 63,703 | $ | 105,590 | |||||||||||||||
Diluted earnings per share from continuing operations attributable to The Andersons, Inc. common shareholders | $ | 0.28 | $ | 0.50 | $ | 1.46 | $ | 3.02 | |||||||||||||||
Impact on diluted earnings (loss) per share from continuing operations | $ | (0.15) | $ | — | $ | 0.40 | $ | 0.05 | |||||||||||||||
Adjusted diluted earnings per share from continuing operations | $ | 0.13 | $ | 0.50 | $ | 1.86 | $ | 3.07 | |||||||||||||||
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended September 30, 2023 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 2,639,059 | $ | 868,099 | $ | 128,533 | $ | — | $ | 3,635,691 | |||||||||||||||||||
Gross profit | 85,997 | 53,045 | 18,659 | — | 157,701 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 79,247 | 8,332 | 26,233 | 12,494 | 126,306 | ||||||||||||||||||||||||
Other income, net | 7,838 | 3,346 | 606 | 3,388 | 15,178 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 8,073 | 47,096 | (8,452) | (8,332) | 38,385 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 20,815 | — | — | 20,815 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 8,073 | $ | 26,281 | $ | (8,452) | $ | (8,332) | $ | 17,570 | |||||||||||||||||||
Adjustments to income (loss) before income taxes from continuing operations2 | (2,681) | — | — | (4,798) | (7,479) | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 5,392 | $ | 26,281 | $ | (8,452) | $ | (13,130) | $ | 10,091 | |||||||||||||||||||
Three months ended September 30, 2022 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 3,240,526 | $ | 814,923 | $ | 163,876 | $ | — | $ | 4,219,325 | |||||||||||||||||||
Gross profit | 124,368 | 24,677 | 14,720 | — | 163,765 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 73,347 | 7,053 | 25,427 | 9,712 | 115,539 | ||||||||||||||||||||||||
Other income (loss), net | 419 | 832 | 1,018 | (794) | 1,475 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 40,658 | 15,901 | (11,609) | (10,231) | 34,719 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 7,524 | — | — | 7,524 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 40,658 | $ | 8,377 | $ | (11,609) | $ | (10,231) | $ | 27,195 | |||||||||||||||||||
1 Income (loss) from continuing operations before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income. 2 Additional information on the individual adjustments that are included in the adjustments to income (loss) from continuing operations before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table. | |||||||||||||||||||||||||||||
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Nine months ended September 30, 2023 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 8,213,649 | $ | 2,585,396 | $ | 738,067 | $ | — | $ | 11,537,112 | |||||||||||||||||||
Gross profit | 283,886 | 137,140 | 106,623 | — | 527,649 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 220,373 | 24,804 | 79,251 | 35,120 | 359,548 | ||||||||||||||||||||||||
Other income, net | 18,149 | 11,655 | 1,952 | 3,867 | 35,623 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 52,427 | 31,187 | 23,675 | (29,487) | 77,802 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 4,088 | — | — | 4,088 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 52,427 | $ | 27,099 | $ | 23,675 | $ | (29,487) | $ | 73,714 | |||||||||||||||||||
Adjustments to income (loss) before income taxes from continuing operations2 | (16,154) | 37,906 | — | (4,798) | 16,954 | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 36,273 | $ | 65,005 | $ | 23,675 | $ | (34,285) | $ | 90,668 | |||||||||||||||||||
Nine months ended September 30, 2022 | |||||||||||||||||||||||||||||
Sales and merchandising revenues | $ | 9,422,974 | $ | 2,380,721 | $ | 844,201 | $ | — | $ | 12,647,896 | |||||||||||||||||||
Gross profit | 293,981 | 99,756 | 120,404 | — | 514,141 | ||||||||||||||||||||||||
Operating, administrative and general expenses | 195,867 | 23,533 | 80,343 | 30,342 | 330,085 | ||||||||||||||||||||||||
Other income (loss), net | 2,148 | 19,750 | 2,688 | (2,401) | 22,185 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations | 67,993 | 89,639 | 37,445 | (31,598) | 163,479 | ||||||||||||||||||||||||
Income attributable to noncontrolling interests | — | 29,827 | — | — | 29,827 | ||||||||||||||||||||||||
Income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 67,993 | $ | 59,812 | $ | 37,445 | $ | (31,598) | $ | 133,652 | |||||||||||||||||||
Adjustments to income before income taxes from continuing operations2 | 693 | — | — | — | 693 | ||||||||||||||||||||||||
Adjusted income (loss) before income taxes from continuing operations attributable to The Andersons, Inc.1 | $ | 68,686 | $ | 59,812 | $ | 37,445 | $ | (31,598) | $ | 134,345 | |||||||||||||||||||
1 Income (loss) from continuing operations before income taxes attributable to The Andersons, Inc. for each operating segment is defined as net sales and merchandising revenues plus identifiable other income less all identifiable operating expenses, including interest expense for carrying working capital and long-term assets and is reported net of the noncontrolling interest share of income. 2 Additional information on the individual adjustments that are included in the adjustments to income (loss) from continuing operations before income taxes can be found in the Reconciliation to EBITDA and Adjusted EBITDA table. |
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Three months ended September 30, 2023 | |||||||||||||||||||||||||||||
Net income (loss)1 | $ | 8,073 | $ | 47,096 | $ | (8,452) | $ | (16,194) | $ | 30,523 | |||||||||||||||||||
Interest expense (income) | 6,515 | 963 | 1,484 | (774) | 8,188 | ||||||||||||||||||||||||
Tax provision | — | — | — | 7,862 | 7,862 | ||||||||||||||||||||||||
Depreciation and amortization | 9,331 | 12,328 | 7,464 | 2,092 | 31,215 | ||||||||||||||||||||||||
EBITDA1 | 23,919 | 60,387 | 496 | (7,014) | 77,788 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 1,999 | — | — | — | 1,999 | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Gain on sale of assets | (5,643) | — | — | — | (5,643) | ||||||||||||||||||||||||
Impairment on equity method investment | 963 | — | — | — | 963 | ||||||||||||||||||||||||
Total adjusting items | (2,681) | — | — | (4,798) | (7,479) | ||||||||||||||||||||||||
Adjusted EBITDA1 | $ | 21,238 | $ | 60,387 | $ | 496 | $ | (11,812) | $ | 70,309 | |||||||||||||||||||
Three months ended September 30, 2022 | |||||||||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 40,658 | $ | 15,901 | $ | (11,609) | $ | (20,070) | $ | 24,880 | |||||||||||||||||||
Interest expense (income) | 10,782 | 2,555 | 1,920 | (275) | 14,982 | ||||||||||||||||||||||||
Tax provision | — | — | — | 9,839 | 9,839 | ||||||||||||||||||||||||
Depreciation and amortization | 9,011 | 15,501 | 6,626 | 2,184 | 33,322 | ||||||||||||||||||||||||
EBITDA from continuing operations | $ | 60,451 | $ | 33,957 | $ | (3,063) | $ | (8,322) | $ | 83,023 | |||||||||||||||||||
(in thousands) | Trade | Renewables | Nutrient & Industrial | Other | Total | ||||||||||||||||||||||||
Nine months ended September 30, 2023 | |||||||||||||||||||||||||||||
Net income (loss)1 | $ | 52,427 | $ | 31,187 | $ | 23,675 | $ | (53,197) | $ | 54,092 | |||||||||||||||||||
Interest expense (income) | 29,235 | 5,648 | 5,649 | (1,766) | 38,766 | ||||||||||||||||||||||||
Tax provision | — | — | — | 23,710 | 23,710 | ||||||||||||||||||||||||
Depreciation and amortization | 26,659 | 39,224 | 21,518 | 6,399 | 93,800 | ||||||||||||||||||||||||
EBITDA1 | 108,321 | 76,059 | 50,842 | (24,854) | 210,368 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Transaction related compensation | 4,606 | — | — | — | 4,606 | ||||||||||||||||||||||||
Insured inventory recoveries | (16,080) | — | — | — | (16,080) | ||||||||||||||||||||||||
Gain on sale of assets | (5,643) | — | — | — | (5,643) | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Asset impairment including equity method investment | 963 | 87,156 | — | — | 88,119 | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | (6,544) | — | — | (6,544) | ||||||||||||||||||||||||
Total adjusting items | (16,154) | 80,612 | — | (4,798) | 59,660 | ||||||||||||||||||||||||
Adjusted EBITDA1 | $ | 92,167 | $ | 156,671 | $ | 50,842 | $ | (29,652) | $ | 270,028 | |||||||||||||||||||
Nine months ended September 30, 2022 | |||||||||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 67,993 | $ | 89,639 | $ | 37,445 | $ | (61,293) | $ | 133,784 | |||||||||||||||||||
Interest expense (income) | 32,269 | 6,334 | 5,304 | (1,145) | 42,762 | ||||||||||||||||||||||||
Tax provision | — | — | — | 29,695 | 29,695 | ||||||||||||||||||||||||
Depreciation and amortization | 26,899 | 48,015 | 19,800 | 6,552 | 101,266 | ||||||||||||||||||||||||
EBITDA from continuing operations | 127,161 | 143,988 | 62,549 | (26,191) | 307,507 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA: | |||||||||||||||||||||||||||||
Gain on sale of assets | (3,762) | — | — | — | (3,762) | ||||||||||||||||||||||||
Impairment on equity method investment | 4,455 | — | — | — | 4,455 | ||||||||||||||||||||||||
Total adjusting items | 693 | — | — | — | 693 | ||||||||||||||||||||||||
Adjusted EBITDA from continuing operations | $ | 127,854 | $ | 143,988 | $ | 62,549 | $ | (26,191) | $ | 308,200 |
Three Months Ended, | Twelve months ended September 30, 2023 | ||||||||||||||||||||||||||||
(in thousands) | December 31, 2022 | March 31, 2023 | June 30, 2023 | September 30, 2023 | |||||||||||||||||||||||||
Net income (loss) from continuing operations | $ | 21,170 | $ | (59,117) | $ | 82,686 | $ | 30,523 | $ | 75,262 | |||||||||||||||||||
Interest expense | 14,087 | 16,625 | 13,953 | 8,188 | 52,853 | ||||||||||||||||||||||||
Tax provision (benefit) | 9,933 | (5,884) | 21,732 | 7,862 | 33,643 | ||||||||||||||||||||||||
Depreciation and amortization | 33,476 | 32,220 | 30,365 | 31,215 | 127,276 | ||||||||||||||||||||||||
EBITDA from continuing operations | 78,666 | (16,156) | 148,736 | 77,788 | 289,034 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA from continuing operations: | |||||||||||||||||||||||||||||
Transaction related compensation expense | — | 1,668 | 939 | 1,999 | 4,606 | ||||||||||||||||||||||||
Gain on sale of assets | — | — | — | (5,643) | (5,643) | ||||||||||||||||||||||||
Gain on cost method investment | — | — | — | (4,798) | (4,798) | ||||||||||||||||||||||||
Asset impairment including equity method investments | 9,000 | 87,156 | — | 963 | 97,119 | ||||||||||||||||||||||||
Insured inventory expenses (recoveries) | 15,993 | (17,390) | 1,310 | — | (87) | ||||||||||||||||||||||||
Gain on deconsolidation of joint venture | — | — | (6,544) | — | (6,544) | ||||||||||||||||||||||||
Total adjusting items | 24,993 | 71,434 | (4,295) | (7,479) | 84,653 | ||||||||||||||||||||||||
Adjusted EBITDA from continuing operations | $ | 103,659 | $ | 55,278 | $ | 144,441 | $ | 70,309 | $ | 373,687 | |||||||||||||||||||
Three Months Ended, | Twelve months ended September 30, 2022 | ||||||||||||||||||||||||||||
December 31, 2021 | March 31, 2022 | June 30, 2022 | September 30, 2022 | ||||||||||||||||||||||||||
Net income from continuing operations | $ | 65,473 | $ | 6,504 | $ | 102,400 | $ | 24,880 | $ | 199,257 | |||||||||||||||||||
Interest expense | 8,444 | 10,859 | 16,921 | 14,982 | 51,206 | ||||||||||||||||||||||||
Tax provision | 11,163 | 4,103 | 15,753 | 9,839 | 40,858 | ||||||||||||||||||||||||
Depreciation and amortization | 36,797 | 34,377 | 33,567 | 33,322 | 138,063 | ||||||||||||||||||||||||
EBITDA from continuing operations | 121,877 | 55,843 | 168,641 | 83,023 | 429,384 | ||||||||||||||||||||||||
Adjusting items impacting EBITDA from continuing operations: | |||||||||||||||||||||||||||||
Transaction related compensation expense | 274 | — | — | — | 274 | ||||||||||||||||||||||||
Asset impairments including equity method investments | 8,321 | — | 4,455 | — | 12,776 | ||||||||||||||||||||||||
Gain on sales of assets | — | — | (3,762) | — | (3,762) | ||||||||||||||||||||||||
Total adjusting items | 8,595 | — | 693 | — | 9,288 | ||||||||||||||||||||||||
Adjusted EBITDA from continuing operations | $ | 130,472 | $ | 55,843 | $ | 169,334 | $ | 83,023 | $ | 438,672 | |||||||||||||||||||
Three months ended September 30, | Nine months ended September 30, | ||||||||||||||||||||||
(in thousands) | 2023 | 2022 | 2023 | 2022 | |||||||||||||||||||
Cash provided by (used in) operating activities | $ | 488,683 | $ | 568,429 | $ | 696,087 | $ | (153,370) | |||||||||||||||
Changes in operating assets and liabilities | |||||||||||||||||||||||
Accounts receivable | 198,396 | 148,330 | 406,263 | (140,866) | |||||||||||||||||||
Inventories | 13,263 | 50,169 | 748,118 | 236,854 | |||||||||||||||||||
Commodity derivatives | (3,274) | 84,189 | 99,479 | (104,901) | |||||||||||||||||||
Other current and non-current assets | 3,295 | (3,106) | 2,048 | 2,000 | |||||||||||||||||||
Payables and other current and non-current liabilities | 214,870 | 238,184 | (796,216) | (371,219) | |||||||||||||||||||
Total changes in operating assets and liabilities | 426,550 | 517,766 | 459,692 | (378,132) | |||||||||||||||||||
Adjusting items impacting cash from operations before working capital changes: | |||||||||||||||||||||||
Less: Insured inventory recoveries | — | — | (16,080) | — | |||||||||||||||||||
Less: Unrealized foreign currency losses on receivables | (12,088) | — | (12,088) | — | |||||||||||||||||||
Cash from operations before working capital changes | $ | 50,045 | $ | 50,663 | $ | 208,227 | $ | 224,762 |